Fawn Incor

NIFEDIL PR 20 Tablets are an advanced prolonged-release antihypertensive formulation designed to provide effective 24-hour blood pressure control while supporting cardiovascular health and reducing the risk of angina episodes. Formulated with Nifedipine 20 mg Prolonged Release, it delivers sustained calcium channel blockade, helping relax vascular smooth muscles, reduce peripheral vascular resistance, and improve blood flow with consistent therapeutic efficacy.

Key Benefits

🔹 24-Hour Blood Pressure Control with Prolonged-Release Nifedipine
The prolonged-release formulation provides sustained antihypertensive action, helping maintain stable blood pressure throughout the day and improving treatment adherence.

🔹 Effective Blood Pressure Management
Nifedipine relaxes vascular smooth muscles by blocking calcium influx, reducing peripheral vascular resistance and helping achieve effective control of hypertension.

🔹 Supports Healthy Coronary Blood Flow
Improves coronary circulation and reduces myocardial oxygen demand, helping prevent angina attacks and support overall cardiovascular function.

🔹 Minimizes Blood Pressure Fluctuations
The prolonged-release delivery system ensures gradual drug release, promoting consistent blood pressure control and reducing peak-to-trough variations.

🔹 Long-Term Cardiovascular Protection
Provides reliable therapy for patients with hypertension and chronic angina, supporting long-term cardiovascular health and reducing cardiovascular risk.

Therapeutic Uses

• Essential Hypertension
• Chronic Stable Angina
• Vasospastic (Prinzmetal's) Angina
• Long-Term Cardiovascular Risk Management in Hypertensive Patients
• Prevention of Angina Attacks

Reference

European Society of Cardiology (ESC). Guidelines for the Management of Arterial Hypertension. 2024.

📌 Disclaimer:
This product is intended for use under the supervision of a registered medical practitioner. The information provided is for educational purposes and is not intended for promotional use.

PITABAC 1.125 Injection is an advanced broad-spectrum antibacterial formulation designed to provide effective treatment of moderate to severe bacterial infections while combating β-lactamase-mediated resistance. Formulated with Piperacillin 1000 mg and Tazobactam 125 mg, it delivers synergistic antibacterial activity against a wide range of Gram-positive, Gram-negative, and anaerobic bacteria, supporting reliable infection control and improved clinical outcomes.

Key Benefits

🔹 Broad-Spectrum Antibacterial Protection with Potent β-Lactamase Inhibition
The synergistic combination of Piperacillin and Tazobactam provides comprehensive antibacterial coverage while enhancing efficacy against β-lactamase-producing organisms.

🔹 Provides Broad-Spectrum Antibacterial Activity
Piperacillin inhibits bacterial cell wall synthesis, helping eliminate susceptible Gram-positive, Gram-negative, and anaerobic pathogens effectively.

🔹 Enhances Activity Against Resistant Bacteria
Tazobactam protects Piperacillin from β-lactamase-mediated degradation, extending its antibacterial spectrum and improving activity against resistant bacterial strains.

🔹 Effective in Moderate to Severe Bacterial Infections
Provides dependable antimicrobial therapy for complicated infections requiring prompt and comprehensive antibacterial intervention.

🔹 Reliable Support for Hospital & Critical Care Management
Useful in respiratory, urinary, intra-abdominal, skin, soft tissue, gynecological, and systemic bacterial infections, supporting improved patient outcomes in hospital settings.

Therapeutic Uses

• Lower Respiratory Tract Infections
• Urinary Tract Infections (UTIs)
• Intra-Abdominal Infections
• Skin & Soft Tissue Infections
• Gynecological Infections
• Septicemia & Other Severe Bacterial Infections

Reference

Sanford Guide to Antimicrobial Therapy. 2025 Edition.

📌 Disclaimer:
This product is intended for use under strict medical supervision only. The information provided is for educational purposes and is not intended for promotional use.

PRITEL TRIO Tablets are an advanced antihypertensive formulation designed to provide comprehensive support for blood pressure control, cardiovascular protection, and long-term vascular health. Formulated with Telmisartan 40 mg, Amlodipine 5 mg, and Hydrochlorothiazide 12.5 mg, it delivers triple-action therapy to help effectively lower blood pressure, improve vascular function, reduce fluid overload, and support sustained cardiovascular wellness.

Key Benefits

🔹 Triple Action for Effective Blood Pressure Control
The synergistic combination of Telmisartan, Amlodipine, and Hydrochlorothiazide provides comprehensive blood pressure management through complementary mechanisms of action.

🔹 Supports Sustained Blood Pressure Reduction
Telmisartan blocks the effects of angiotensin II, while Amlodipine relaxes blood vessels and Hydrochlorothiazide helps eliminate excess sodium and water, promoting effective and sustained blood pressure control.

🔹 Provides Comprehensive Cardiovascular Protection
Helps reduce cardiovascular workload, improve vascular function, and support long-term heart and blood vessel health in patients with hypertension.

🔹 Optimized Therapy for Patients Inadequately Controlled on Monotherapy
Useful in individuals requiring combination antihypertensive therapy to achieve target blood pressure and improve overall treatment outcomes.

🔹 Reliable Support for Long-Term Hypertension Management
Provides effective long-term blood pressure control in patients with essential hypertension and cardiovascular risk factors, helping improve overall cardiovascular health and quality of life.

Therapeutic Uses

• Essential Hypertension
• Patients Inadequately Controlled on Monotherapy
• Long-Term Blood Pressure Management
• Hypertensive Patients with Cardiovascular Risk Factors

Reference

Burnier M, Egan BM. Adherence in Hypertension. Circulation Research. 2019;124(7):1124–1140.

📌 Disclaimer:
This product is intended for use under strict medical supervision only. The information provided is for educational purposes and is not intended for promotional use.

MOLOZOL D Capsules are an advanced gastrointestinal care formulation designed to provide effective relief from acid-related disorders, nausea, and digestive discomfort. Formulated with Omeprazole 20 mg and Domperidone 10 mg, it delivers dual-action therapy to help suppress excess stomach acid, improve gastric motility, and provide lasting relief from reflux, heartburn, and associated nausea.

Key Benefits

🔹 Complete Relief from Acid & Nausea
Omeprazole effectively suppresses gastric acid secretion, while Domperidone improves gastric emptying, providing comprehensive relief from acid reflux and nausea.

🔹 Supports Relief from GERD & Heartburn
Helps reduce heartburn, acid regurgitation, and reflux symptoms by controlling excess stomach acid and improving digestive comfort.

🔹 Improves Gastric Motility & Digestive Function
Domperidone enhances gastric emptying and reduces gastric stasis, helping relieve bloating, fullness, and digestive discomfort.

🔹 Helps Control Nausea & Dyspeptic Symptoms
Provides effective relief from nausea, indigestion, and dyspepsia while supporting improved gastrointestinal function and patient comfort.

🔹 Comprehensive Gastrointestinal Wellness Support
Useful in GERD, acid peptic disease, gastritis, and dyspepsia associated with nausea, helping improve digestive health and overall quality of life.

Therapeutic Uses

• Gastroesophageal Reflux Disease (GERD)
• Acid Peptic Disease (APD)
• Dyspepsia with Nausea
• Gastritis

Reference

ACG Clinical Guideline: Gastroesophageal Reflux Disease (GERD). American Journal of Gastroenterology. 2022.

📌 Disclaimer:
This product is intended for use under strict medical supervision only. The information provided is for educational purposes and is not intended for promotional use.

MOLOZOL 20 Capsules are an advanced proton pump inhibitor (PPI) formulation designed to provide effective acid suppression and long-lasting relief from acid-related gastrointestinal disorders. Formulated with Omeprazole I.P. 20 mg, it helps reduce gastric acid secretion, promote healing of the upper gastrointestinal mucosa, and support long-term digestive comfort.

Key Benefits

🔹 Effective Acid Suppression for Lasting Comfort
Omeprazole effectively inhibits gastric acid secretion by blocking the proton pump, providing sustained relief from acid-related symptoms and promoting gastrointestinal healing.

🔹 Supports Relief from Heartburn & Acid Reflux
Helps reduce heartburn, acid regurgitation, and reflux symptoms associated with gastroesophageal reflux disease (GERD), improving daily comfort and quality of life.

🔹 Promotes Healing of Gastric & Duodenal Ulcers
Supports healing of acid-induced gastric and duodenal ulcers by maintaining reduced gastric acidity and protecting the gastrointestinal mucosa.

🔹 Provides Long-Lasting Control of Acid-Related Disorders
Offers prolonged acid suppression, helping manage chronic acid peptic disease and erosive esophagitis while reducing the risk of symptom recurrence.

🔹 Comprehensive Gastrointestinal Care Support
Useful in GERD, peptic ulcer disease, acid peptic disease, and erosive esophagitis, providing reliable long-term management of acid-related gastrointestinal conditions.

Therapeutic Uses

• Gastroesophageal Reflux Disease (GERD)
• Peptic Ulcer Disease (Gastric & Duodenal Ulcers)
• Acid Peptic Disease (APD)
• Erosive Esophagitis

Reference

Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology. 2022.

📌 Disclaimer:
This product is intended for use under strict medical supervision only. The information provided is for educational purposes and is not intended for promotional use.

MILOXIN DX Ear/Eye Drops are an advanced antibacterial and anti-inflammatory formulation designed to provide effective management of bacterial eye and ear infections associated with inflammation. Formulated with Polymyxin B Sulphate, Chloramphenicol, and Dexamethasone, it delivers broad-spectrum antibacterial protection while helping reduce redness, swelling, irritation, and discomfort for improved ocular and otic care.

Key Benefits

🔹 Combining Antibacterial Action with Anti-inflammatory Support
The synergistic combination of broad-spectrum antibiotics and a corticosteroid helps eliminate susceptible bacteria while effectively controlling inflammation and associated symptoms.

🔹 Broad-Spectrum Protection Against Bacterial Infections
Polymyxin B Sulphate and Chloramphenicol work together to inhibit and eliminate a wide range of susceptible Gram-positive and Gram-negative bacteria, supporting effective infection control.

🔹 Helps Reduce Redness, Swelling & Discomfort
Dexamethasone helps reduce inflammation, redness, edema, and irritation associated with bacterial eye and ear infections, promoting faster symptomatic relief.

🔹 Supports Faster Recovery in Eye & Ear Infections
Provides effective management of infected inflammatory conditions by combining potent antimicrobial action with anti-inflammatory support for improved clinical outcomes.

🔹 Comprehensive Ophthalmic & Otic Care
Useful in bacterial conjunctivitis, blepharitis, otitis externa, and other susceptible inflammatory eye and ear infections, supporting faster recovery and enhanced patient comfort.

Therapeutic Uses

• Bacterial Conjunctivitis
• Blepharitis
• Otitis Externa
• Infected Inflammatory Eye & Ear Conditions

Reference

American Academy of Ophthalmology (AAO). Preferred Practice Pattern®: Bacterial Keratitis. 2023.

📌 Disclaimer:
This product is intended for use under strict medical supervision only. The information provided is for educational purposes and is not intended for promotional use.

OTOSET MD 8 Tablets contain Ondansetron 8 mg, a selective 5-HT3 receptor antagonist formulated as a mouth-dissolving tablet to provide rapid and effective relief from nausea and vomiting. The fast-dissolving formulation melts quickly on the tongue without the need for water, making it a convenient option for patients experiencing nausea associated with chemotherapy, radiotherapy, surgery, and gastrointestinal disorders.

Key Benefits

🔹 Rapid Mouth-Dissolving Action
The orally disintegrating formulation dissolves quickly on the tongue without water, ensuring convenient administration and faster patient compliance.

🔹 Effective Prevention & Control of Nausea and Vomiting
Ondansetron selectively blocks 5-HT3 receptors, helping prevent and control nausea and vomiting triggered by chemotherapy, radiotherapy, surgery, and various gastrointestinal conditions.

🔹 Reliable Support During Cancer Therapy
Provides effective management of chemotherapy-induced and radiation therapy-induced nausea and vomiting, improving patient comfort and treatment adherence.

🔹 Ideal for Post-Operative Care
Offers dependable control of post-operative nausea and vomiting, supporting faster recovery and enhanced patient well-being.

🔹 Trusted Clinical Performance
A well-established antiemetic therapy that delivers reliable symptomatic relief across a wide range of nausea and vomiting conditions under medical supervision.

Therapeutic Uses

• Nausea & Vomiting in Gastroenteritis
• Chemotherapy-Induced Nausea & Vomiting (CINV)
• Radiation Therapy-Induced Nausea & Vomiting (RINV)
• Post-Operative Nausea & Vomiting (PONV)

Reference

Navari RM. Management of Chemotherapy-Induced Nausea and Vomiting. Drugs. 2013;73(3):249–262.

📌 Disclaimer:
This product is intended for use under strict medical supervision only. The information provided is for educational purposes and is not intended for promotional use.

OLIZID T Injection is a potent antibacterial combination formulated with Ceftazidime 1000 mg and Tobramycin 120 mg to provide broad-spectrum coverage against serious bacterial infections. The synergistic action of a third-generation cephalosporin and an aminoglycoside antibiotic ensures enhanced bactericidal activity against a wide range of Gram-negative pathogens, including difficult-to-treat hospital-acquired organisms.

Key Benefits

🔹 Broad-Spectrum Antibacterial Activity
Ceftazidime provides extensive coverage against Gram-negative bacteria by inhibiting bacterial cell wall synthesis, helping eliminate susceptible pathogens effectively.

🔹 Enhanced Bactericidal Synergy
Tobramycin complements Ceftazidime through inhibition of bacterial protein synthesis, offering rapid and powerful antimicrobial action.

🔹 Effective Against Severe & Complicated Infections
Designed for the management of serious infections where dependable and comprehensive antimicrobial coverage is required.

🔹 Supports Critical Care Management
Commonly utilized in hospital and critical care settings for infections caused by susceptible Gram-negative organisms, including challenging nosocomial pathogens.

🔹 Reliable Clinical Performance
Provides a well-established therapeutic option for the treatment of complicated infections requiring prompt and effective antibacterial intervention.

Therapeutic Uses

• Lower Respiratory Tract Infections
• Complicated Urinary Tract Infections (UTIs)
• Septicemia & Bacteremia
• Intra-Abdominal Infections
• Skin & Soft Tissue Infections
• Bone & Joint Infections

Reference

Paul M, et al. Beta-lactam–aminoglycoside combination therapy for sepsis. Cochrane Database of Systematic Reviews. 2022.

📌 Disclaimer:
This product is intended for use under strict medical supervision only. The information provided is for educational purposes and is not intended for promotional use.

GOUTAB 80 Tablets are an advanced urate-lowering therapy designed to provide effective support for uric acid control, gout management, and long-term joint health. Formulated with Febuxostat 80 mg, it helps reduce elevated serum uric acid levels, prevent gout flares, and support overall musculoskeletal wellness by targeting the root cause of hyperuricemia.
Key Benefits

🔹 Selective Approach to Hyperuricemia Management
Febuxostat selectively inhibits xanthine oxidase, the enzyme responsible for uric acid production, helping achieve effective and sustained uric acid control.

🔹 Supports Long-Term Gout Management
Helps reduce serum uric acid levels, supporting the prevention of recurrent gout attacks and improving long-term disease management.

🔹 Helps Prevent Tophi Formation & Joint Damage
By maintaining healthy uric acid levels, it helps reduce urate crystal deposition, minimizing the risk of tophi formation and progressive joint complications.

🔹 Supports Renal Health Associated with Uric Acid Disorders
Useful in chronic uric acid nephropathy and prevention of uric acid-related kidney stone formation by helping control hyperuricemia.

🔹 Comprehensive Protection Against Uric Acid Complications
Provides reliable long-term support for patients with gout and hyperuricemia, helping improve joint comfort, mobility, and quality of life.

Therapeutic Uses

• Gout & Hyperuricemia
• Chronic Uric Acid Nephropathy
• Prevention of Uric Acid-Related Kidney Stones
• Management of Tumor Lysis Syndrome (Off-Label Use)

Reference:

FitzGerald JD, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care & Research. 2020;72(6):744–760.

📌 Disclaimer:
This product is intended for use under strict medical supervision only. The information provided is for educational purposes and is not intended for promotional use.

TORACIN 500 Tablets are an advanced broad-spectrum antibiotic therapy designed to provide effective protection against bacterial infections and support faster recovery from infectious conditions. Enriched with Azithromycin 500 mg, it helps inhibit bacterial protein synthesis, control susceptible microorganisms, and support comprehensive infection management across multiple systems.

Key Benefits

🔹 Broad-Spectrum Protection Against Bacterial Infections
Azithromycin provides effective antibacterial action against a wide range of Gram-positive and Gram-negative pathogens, supporting reliable infection control.

🔹 Supports Respiratory & ENT Infection Management
Helps manage respiratory tract infections, tonsillitis, pharyngitis, and otitis media by reducing bacterial growth and associated inflammatory symptoms.

🔹 Helps Control Skin & Soft Tissue Infections
Useful in bacterial skin and soft tissue infections, supporting faster symptomatic relief and recovery.

🔹 Reliable Support in Urogenital Infections
Provides effective antibacterial therapy in selected genitourinary infections, helping support microbial eradication and patient wellness.

🔹 Comprehensive Infection Care with Convenient Dosing
Widely preferred for its dependable efficacy, favorable tolerability, and convenient dosing schedule, supporting improved patient compliance and treatment outcomes.

Therapeutic Uses

• Respiratory Tract Infections
• Tonsillitis & Pharyngitis
• Skin & Soft Tissue Infections
• Otitis Media
• Urogenital Infections

Reference:
Wong EH, et al. Role of azithromycin in respiratory tract infections. Drugs. 2017;77(12):1315–1331.

📌 Disclaimer:
This product is intended for use under strict medical supervision only. The information provided is for educational purposes and is not intended for promotional use.